| __timestamp | Amphastar Pharmaceuticals, Inc. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 28427000 | 11768000 |
| Thursday, January 1, 2015 | 37065000 | 15152000 |
| Friday, January 1, 2016 | 41199000 | 19828000 |
| Sunday, January 1, 2017 | 43415000 | 25573000 |
| Monday, January 1, 2018 | 57564000 | 23634000 |
| Tuesday, January 1, 2019 | 68853000 | 38845000 |
| Wednesday, January 1, 2020 | 67229000 | 50523000 |
| Friday, January 1, 2021 | 60932000 | 75463000 |
| Saturday, January 1, 2022 | 74771000 | 105767000 |
| Sunday, January 1, 2023 | 73741000 | 167512000 |
Unleashing the power of data
In the ever-evolving world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Xenon Pharmaceuticals Inc. and Amphastar Pharmaceuticals, Inc. have demonstrated contrasting yet intriguing R&D investment strategies. From 2014 to 2023, Xenon Pharmaceuticals Inc. increased its R&D spending by over 1,300%, peaking in 2023 with a budget that was nearly 2.3 times that of Amphastar Pharmaceuticals, Inc. This surge underscores Xenon's commitment to pioneering new treatments. Meanwhile, Amphastar Pharmaceuticals, Inc. maintained a steady growth trajectory, with a 160% increase in R&D expenses over the same period. This consistent investment reflects a balanced approach to innovation and market stability. As these companies continue to navigate the competitive landscape, their R&D strategies will be pivotal in shaping the future of healthcare.
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.
Research and Development Investment: Incyte Corporation vs Xenon Pharmaceuticals Inc.
R&D Insights: How Ascendis Pharma A/S and Xenon Pharmaceuticals Inc. Allocate Funds
R&D Spending Showdown: Pharming Group N.V. vs Amphastar Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Verona Pharma plc vs Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: ADMA Biologics, Inc. vs Amphastar Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for CRISPR Therapeutics AG and Amphastar Pharmaceuticals, Inc.
Comparing Innovation Spending: Xenon Pharmaceuticals Inc. and ImmunityBio, Inc.
Cost Insights: Breaking Down Xenon Pharmaceuticals Inc. and Amphastar Pharmaceuticals, Inc.'s Expenses
R&D Spending Showdown: Soleno Therapeutics, Inc. vs Amphastar Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Agios Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.
Iovance Biotherapeutics, Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?